We are live on ! Find out more
EW icon

Edwards Lifesciences
EW

838 hedge funds and large institutions have $25.5B invested in Edwards Lifesciences in 2018 Q2 according to their latest regulatory filings, with 82 funds opening new positions, 286 increasing their positions, 314 reducing their positions, and 54 closing their positions.

New
Increased
Maintained
Reduced
Closed

52% more first-time investments, than exits

New positions opened: 82 | Existing positions closed: 54

11% more call options, than puts

Call options by funds: $152M | Put options by funds: $136M

5% more funds holding in top 10

Funds holding in top 10: 21 → 22 (+1)

3% more funds holding

Funds holding: 815 → 838 (+23)

5% more capital invested

Capital invested by funds: $24.3B → $25.5B (+$1.16B)

0.55% more ownership

Funds ownership: 249.42% → 249.97% (+0.55%)

9% less repeat investments, than reductions

Existing positions increased: 286 | Existing positions reduced: 314

Holders
838
Holders Change
+23
Holders Change %
+2.82%
% of All Funds
19.18%
Holding in Top 10
22
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+4.76%
% of All Funds
0.5%
New
82
Increased
286
Reduced
314
Closed
54
Calls
$152M
Puts
$136M
Net Calls
+$15.6M
Net Calls Change
-$6.4M

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$233M
2
Capital Research Global Investors
Capital Research Global Investors
California
+$187M
3
TCIM
TIAA CREF Investment Management
New York
+$109M
4
WCM Investment Management
WCM Investment Management
California
+$63.4M
5
Invesco
Invesco
Georgia
+$57M

Top Sellers

1
Goldman Sachs
Goldman Sachs
New York
-$88.9M
2
Ameriprise
Ameriprise
Minnesota
-$80.6M
3
Renaissance Technologies
Renaissance Technologies
New York
-$71.7M
4
Two Sigma Advisers
Two Sigma Advisers
New York
-$71.7M
5
Bank of New York Mellon
Bank of New York Mellon
New York
-$70.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
RWP
826
RWA Wealth Partners
Massachusetts
$3K – – –
CA
827
Centerpoint Advisors
Massachusetts
$3K +$3.36K +72 New
EMG
828
ETF Managers Group
New Jersey
$2.35K +$727K +15,582 +698%
Bessemer Group
829
Bessemer Group
New Jersey
$2K – – –
EFSCE
830
Enterprise Financial Services Corp (EFSC)
Missouri
$2K – – –
GWS
831
Glassman Wealth Services
Virginia
$2K +$560 +12 +36%
FC
832
Ferris Capital
Massachusetts
$2K +$840 +18 +67%
CFC
833
Coyle Financial Counsel
Illinois
$2K +$2.24K +48 New
WAP
834
Wealthcare Advisory Partners
Pennsylvania
$1K -$7K -150 -89%
THWM
835
Taylor Hoffman Wealth Management
Virginia
$1K – – –
AC
836
Avestar Capital
New York
$1K +$560 +12 +19%
AIL
837
AGF Investments LLC
Ontario, Canada
$502 +$483K +10,347 New
NA
838
NewEdge Advisors
Louisiana
$265 +$9.52K +204 +4%
Point72 Asset Management
839
Point72 Asset Management
Connecticut
– -$27.9M -600,000 Closed
Alyeska Investment Group
840
Alyeska Investment Group
Illinois
– -$26.2M -563,007 Closed
RI
841
RTW Investments
New York
– -$20.3M -435,738 Closed
MIM
842
Manitou Investment Management
Ontario, Canada
– -$10.7M -229,944 Closed
GT
843
Glenview Trust
Kentucky
– -$10.5M -225,081 Closed
ARTA
844
A.R.T. Advisors
New York
– -$5.66M -121,800 Closed
FA
845
Friess Associates
Delaware
– -$5.42M -116,550 Closed
PVI
846
Pura Vida Investments
New York
– -$3.49M -75,000 Closed
Fidelity International
847
Fidelity International
Bermuda
– -$3.37M -72,378 Closed
Tudor Investment Corp
848
Tudor Investment Corp
Connecticut
– -$2.72M -58,575 Closed
DF
849
Donoghue Forlines
Massachusetts
– -$2.59M -55,689 Closed
HT
850
HAP Trading
New York
– -$2.41M -51,777 Closed
32 33
34
35 36

EW Hedge Fund Activity: Q2 2018 in Review

838 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Edwards Lifesciences (EW) for Q2 2018, worth a combined $25.5B — up 4.8% from $24.3B a quarter earlier.

Buyers outnumbered sellers: 82 funds opened new EW positions and 54 closed out — a net gain of 28 holders — while 286 added to existing stakes and 314 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $233M. The largest seller was Goldman Sachs, cutting an estimated $88.9M.

  • 838 institutional investors held Edwards Lifesciences (EW) as of Q2 2018, up from 815 in Q1 2018.
  • Funds reported $25.5B of Edwards Lifesciences stock for Q2 2018, up 4.8% quarter-over-quarter.
  • 82 funds opened new Edwards Lifesciences positions in Q2 2018 and 54 closed out, a net change of +28 holders.
  • The largest Edwards Lifesciences buyer in Q2 2018 was Fidelity Investments, an estimated $233M added.
  • The largest Edwards Lifesciences seller in Q2 2018 was Goldman Sachs, an estimated $88.9M sold.

Based on aggregated 13F filings for Q2 2018.